William H. Yang
2036 Main Mall, V6T 1Z1
Vancouver, BC, Canada
Vancouver, BC, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Rapid access to sulfinyl fluorides for the preparation of sulfonimidoyl fluorides.
Journal: Chemical communications (Cambridge, England)
Published: June 23, 2026
Long-Term Integrated Safety and Efficacy of Garadacimab for Hereditary Angioedema Prophylaxis.
Journal: Advances in therapy
Published: February 23, 2026
ICD-11 in Canada: Leveraging crosswalks to evaluate adoption, impact and transition strategies.
Journal: Health information management : journal of the Health Information Management Association of Australia
Published: November 24, 2025
Open-label phase 1b/2 trial of navenibart, a long-acting plasma kallikrein inhibitor for hereditary angioedema.
Journal: The Journal of allergy and clinical immunology
Published: October 17, 2025
Oral deucrictibant for prophylaxis of hereditary angioedema attacks (CHAPTER-1): primary analysis of a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Haematology
Published: September 08, 2025
Oral deucrictibant for on-demand treatment of hereditary angioedema attacks (RAPIDe-1): a randomised, double-blind, placebo-controlled, phase 2 trial.
Journal: The Lancet. Haematology
Published: August 25, 2025
The International/Canadian hereditary angioedema guideline.
Journal: Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology
Published: August 13, 2025
Oral berotralstat for hereditary angioedema prophylaxis in patients aged 2 to <12 years: APeX-P interim results.
Journal: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology
Published: June 03, 2025
The utility of shared decision making in the management of hereditary angioedema.
Journal: Allergy and asthma proceedings
Published: November 09, 2024
Long-Term Safety of Epicutaneous Immunotherapy in Peanut-Allergic Children: An Open-Label Active Treatment (REALISE Study).
Journal: The journal of allergy and clinical immunology. In practice
Published: August 13, 2024
Clinical Response to Cat Allergen in a Mobile Compared to a Fixed Naturalistic Exposure Chamber™.
Journal: International archives of allergy and immunology
Published: July 16, 2024
Varying Doses of Epicutaneous Immunotherapy With Viaskin Milk vs Placebo in Children With Cow's Milk Allergy: A Randomized Clinical Trial.
Journal: JAMA pediatrics
Published: February 26, 2024
Last Updated: 09/26/2026